Regeneron Pharmaceuticals (REGN) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free REGN Stock Alerts $959.92 -4.55 (-0.47%) (As of 03/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of "Moderate Buy" by Brokeragesamericanbankingnews.com - March 19 at 2:34 AMUS appeals court revives Regeneron's antitrust lawsuit against Novartisreuters.com - March 18 at 10:16 AMRegeneron Pharmaceuticals Insiders Sold US$26m Of Shares Suggesting Hesitancyfinance.yahoo.com - March 17 at 10:57 AMAndrew J. Murphy Sells 5,783 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stockinsidertrades.com - March 17 at 4:22 AMBoston Common Asset Management LLC Sells 1,790 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - March 16 at 3:59 PMInsider Selling: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) EVP Sells 5,783 Shares of Stockmarketbeat.com - March 15 at 4:46 PMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by DNB Asset Management ASmarketbeat.com - March 15 at 9:24 AMREGN Mar 2024 885.000 putca.finance.yahoo.com - March 15 at 6:44 AMAnchor Investment Management LLC Purchases New Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - March 14 at 9:25 AMRegeneron Pharmaceuticals, Inc. (REGN) Leerink Partners Global Biopharma Conference (Transcript)seekingalpha.com - March 13 at 1:05 PMThe 3 Most Undervalued Biotech Stocks to Buy in March 2024investorplace.com - March 13 at 10:55 AMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Wellington Management Group LLPmarketbeat.com - March 13 at 9:19 AMRegeneron Pharmaceuticals (NASDAQ:REGN) Receives New Coverage from Analysts at Sanford C. Bernsteinamericanbankingnews.com - March 13 at 2:54 AMHigh School Seniors Win $1.8 Million at Regeneron Science Talent Search 2024 for Innovative Scientific Research on Artificial Intelligence, Cancer Metabolism and Mathematical Optimizationprnewswire.com - March 12 at 11:55 PMHigh School Seniors Win $1.8 Million at Regeneron Science Talent Search 2024 for Innovative Scientific Research on Artificial Intelligence, Cancer Metabolism and Mathematical Optimizationglobenewswire.com - March 12 at 9:30 PMAmerican Century Companies Inc. Purchases 30,050 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - March 12 at 1:47 PMRegeneron Pharmaceuticals, Inc. (REGN) Barclays 26th Annual Global Healthcare Conference (Transcript)seekingalpha.com - March 12 at 1:35 PMRegeneron Pharmaceuticals, Inc. (REGN) Management Presents at Barclays 26th Annual Global Healthcare Conference (Transcript)seekingalpha.com - March 12 at 1:35 PMRegeneron Pharmaceuticals (NASDAQ:REGN) Coverage Initiated at Sanford C. Bernsteinmarketbeat.com - March 12 at 8:21 AMRegeneron Announces FDA Approval Extending Treatment Of Praluent To Children Aged 8markets.businessinsider.com - March 11 at 12:39 PMRegeneron Pharmaceuticals, Inc.: Praluent (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterolfinanznachrichten.de - March 11 at 7:36 AMPraluent® (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterolglobenewswire.com - March 11 at 7:00 AMRoyal Bank of Canada Grows Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - March 10 at 7:33 AMIs There An Opportunity With Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) 42% Undervaluation?finance.yahoo.com - March 9 at 12:36 PMMorgan Stanley Buys 25,792 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - March 9 at 9:24 AMMissed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.fool.com - March 9 at 5:52 AMMercer Global Advisors Inc. ADV Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - March 8 at 9:31 AM2 Biotech Stocks to Buy Hand Over Fist in Marchfool.com - March 8 at 8:15 AMEYLEA® HD (aflibercept) Injection 8 mg Pivotal Data in Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME) Published in The Lancetglobenewswire.com - March 8 at 7:00 AMSchonfeld Strategic Advisors LLC Has $3.32 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - March 7 at 6:39 AMREGN Apr 2024 980.000 callfinance.yahoo.com - March 6 at 5:38 PMThe Manufacturers Life Insurance Company Boosts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - March 6 at 4:39 PMRegeneron Pharmaceuticals, Inc. (REGN) TD Cowen 44th Annual Health Care Conference Call Transcriptseekingalpha.com - March 6 at 3:33 PMAmeriprise Financial Inc. Sells 10,854 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - March 5 at 12:51 PM2seventy bio Inc (TSVT) Reports Mixed Financial Results Amid Strategic Shift and Competitive ...finance.yahoo.com - March 5 at 7:45 AMBiotechs on the Rise: 3 Stocks to Buy for a Shot of Profitsinvestorplace.com - March 4 at 4:09 PMLegal & General Group Plc Sells 26,921 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - March 4 at 12:59 PMRegeneron Pharmaceuticals' (NASDAQ:REGN) investors will be pleased with their impressive 139% return over the last five yearsfinance.yahoo.com - March 4 at 7:27 AMREGN Mar 2024 1050.000 callca.finance.yahoo.com - March 2 at 3:12 AMShelton Capital Management Increases Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - March 1 at 3:47 PMRegeneron Pharmaceuticals Inc at Oppenheimer Healthcare Life Sciences Conference Transcriptgurufocus.com - March 1 at 6:07 AMGENESIS Pharma Announces an Exclusive Distribution Agreement With Regeneron Pharmaceuticals to Commercialize cemiplimab in Greece, Cyprus and Maltabusinesswire.com - March 1 at 3:37 AMREGN Mar 2024 930.000 putsg.finance.yahoo.com - February 29 at 4:08 PMCaisse DE Depot ET Placement DU Quebec Sells 32,187 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - February 29 at 1:40 PMRegeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock Is Going Strong: Is the Market Following Fundamentals?finance.yahoo.com - February 29 at 9:53 AMKarani Asset Management LLC Cuts Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - February 28 at 6:01 PMAnalysts Are Bullish on Top Healthcare Stocks: ANI Pharmaceuticals (ANIP), Boston Scientific (BSX)markets.businessinsider.com - February 27 at 12:59 PMRegeneron Pharmaceuticals (NASDAQ:REGN) Price Target Increased to $1,184.00 by Analysts at Royal Bank of Canadamarketbeat.com - February 27 at 10:25 AMMedian Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Pricesmsn.com - February 26 at 4:15 PMTreasurer of the State of North Carolina Sells 590 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - February 26 at 12:57 PM Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Make This $3 Trade the Instant the Opening Bell Rings (Ad)Since the birth of Wall Street, one simple rule has remained the same.... Buy stocks that are cheap....When they’re on sale…. And when nobody else is looking… See Why This $3.00 Stock Could Hit $15.00 REGN Media Mentions By Week REGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REGN News Sentiment▼0.780.62▲Average Medical News Sentiment REGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REGN Articles This Week▼2014▲REGN Articles Average Week Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Vertex Pharmaceuticals News Bristol-Myers Squibb News Sanofi News GSK News Zoetis News Pfizer News Takeda Pharmaceutical News Royalty Pharma News BeiGene News Catalent News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REGN) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Companytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders Agency Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.